薬学の時間　220203

慢性心不全の効能・効果取得の根拠となったDAPA-HF試験について、SGLT2阻害薬を心不全にどう使うと題してお話は信州大学　循環器内科学　教授　桑原　宏一郎さんです。

Episode metadata supplied by the publisher feed · Published Feb 28, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

薬学の時間　220203

0:00 0:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Similar Episodes

No similar episodes found.

No similar podcasts found.

This episode was published on February 28, 2022.

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!